Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Immune Therapy of Multiple Sclerosis - Future Strategies.
Oxidative stress in multiple sclerosis patients in clinical remission: Association with the expanded disability status scale.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
The structure and function of the S1P1 receptor.
A microbial symbiosis factor prevents intestinal inflammatory disease.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Italian validation of the 12-item multiple sclerosis walking scale.
Longitudinal changes in self-reported walking ability in multiple sclerosis.
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation.
Serum lactate as a novel potential biomarker in multiple sclerosis.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.
Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Perth scientists embark on stroke therapy approach
The Evaluation of the Retinal Nerve Fiber Layer in Multiple Sclerosis with Special-Domain Optical Coherence Tomography.
Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis.
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: Implications for inflammatory demyelinating disease.
Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
Social disruption alters pain and cognition in an animal model of multiple sclerosis.
Oligodendrocyte Precursor Cell-Intrinsic Effect of Rheb1 Controls Differentiation and Mediates mTORC1-Dependent Myelination in Brain.
Immunosuppressive treatments in multiple sclerosis.
Hand dexterity and direct disease related cost in multiple sclerosis.

Pages